| 000 | 01704 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250518062030.0 | ||
| 264 | 0 | _c20200727 | |
| 008 | 202007s 0 0 eng d | ||
| 022 | _a1935-5548 | ||
| 024 | 7 |
_a10.2337/dc19-0855 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLal, Rayhan A | |
| 245 | 0 | 0 |
_aOne Year Clinical Experience of the First Commercial Hybrid Closed-Loop System. _h[electronic resource] |
| 260 |
_bDiabetes care _c12 2019 |
||
| 300 |
_a2190-2196 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Observational Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBlood Glucose _xanalysis |
| 650 | 0 | 4 |
_aBlood Glucose Self-Monitoring _xinstrumentation |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xblood |
| 650 | 0 | 4 | _aEquipment Design |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlycated Hemoglobin _xanalysis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemia _xchemically induced |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aInsulin _xadministration & dosage |
| 650 | 0 | 4 | _aInsulin Infusion Systems |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aBasina, Marina | |
| 700 | 1 | _aMaahs, David M | |
| 700 | 1 | _aHood, Korey | |
| 700 | 1 | _aBuckingham, Bruce | |
| 700 | 1 | _aWilson, Darrell M | |
| 773 | 0 |
_tDiabetes care _gvol. 42 _gno. 12 _gp. 2190-2196 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2337/dc19-0855 _zAvailable from publisher's website |
| 999 |
_c30138665 _d30138665 |
||